<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[lipitor Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/lipitor.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to lipitor]]></description>
	<s:counts start="0" returned="20" found="54" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Pfizer Inc. Q3 2008 Earnings Conference Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-242966.html]]></link>
		<description><![CDATA[ Question-and-Answer Session[Operator Instructions]. Sir, our first question comes from David Risinger of Merrill Lynch. Please proceed with your question. David Risinger - Merrill Lynch Thanks very much. I have two questions. The first is related to Lipitor. On the Lipitor sales, where sales impacted in 2008 or in 2007...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Tue, 21 Oct 2008 12:19:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/operating+margin.html"><![CDATA[Operating Margin]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/question.html"><![CDATA[Question]]></category>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/operating+margin.html"><![CDATA[Operating Margin]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/question.html"><![CDATA[Question]]></category>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Pfizer Cuts a Deal -- No Bid for Ranbaxy]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000103/pfizer-cuts-a-deal-no-bid-for-ranbaxy/]]></link>
		<description><![CDATA[So Pfizer apparently won't be playing the spoiler in the Daiichi-Ranbaxy merger after all. Instead, CEO Jeff Kindler cut a deal with the Indian generics maker that will delay the introduction of generic Lipitor by about 20 months.    Ranbaxy is now spared the cost and uncertainty involved...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 18 Jun 2008 11:35:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[Patent]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[Agreement]]></category>
		<category domain="http://resources.bnet.com/topic/ranbaxy.html"><![CDATA[Ranbaxy]]></category>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[U.S. Patent and Trademark Office to Confirm Patentability of Lipitor Basic Patent]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_30/ai_n25364225]]></link>
		<description><![CDATA[NEW YORK -- Pfizer Inc announced today that the U.S. Patent & Trademark Office has issued a communication notifying the company that it will confirm the patentability of the claims of Pfizer's '893 basic patent for Lipitor. The Patent Office had conducted a re-examination of the '893 patent in response...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 30 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Spanish Appellate Court Rules in Pfizer's Favor, Upholds Lipitor Patent]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_31/ai_n24963878]]></link>
		<description><![CDATA[NEW YORK -- Pfizer Inc said today that the Court of Appeal of Barcelona has upheld the company's enantiomer patent covering the calcium salt of atorvastatin, the active ingredient in Lipitor, reversing the lower court decision. The enantiomer patent expires in July 2010.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 31 Mar 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Pfizer Receives Initial Communication from U.S. Patent and Trademark Office Regarding Lipitor Basic Patent]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Jan_14/ai_n24228980]]></link>
		<description><![CDATA[NEW YORK -- Pfizer Inc announced today that the U.S. Patent & Trademark Office has issued its first communication in the reexamination of the '893 basic patent for Lipitor, initially rejecting the patent's claims. This initial action, which is how the Office raises its issues with the patentee, will now...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 14 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Pfizer to Appeal German Court Decision in Lipitor Patent Case; Company Notes That Ruling Has No Immediate Commercial Impact]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Oct_29/ai_n21068292]]></link>
		<description><![CDATA[NEW YORK -- Pfizer Inc said today that the Federal Patent Court in Munich, Germany has revoked the company's patent covering atorvastatin calcium, the active ingredient in Lipitor. The patent at issue in the lawsuit (EP 409,281) expires in July 2010.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 29 Oct 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Ranbaxy loses battle for Lipitor patent in Canada.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5936/is_200709/ai_n23954766]]></link>
		<description><![CDATA[Sep. 14--NEW DELHI -- In a setback for Ranbaxy in its global battle  over the patent of Lipitor, a Canadian federal court has ruled that the  company's generic drug Atorvastatin infringes upon one of  Pfizer's Lipitor patent. However, the court dismisse  Sep. 14--NEW DELHI -- In...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 14 Sep 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/ranbaxy.html"><![CDATA[Ranbaxy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Pfizer Proves It Can Do More with Lipitor - Protecting Vital Access to Patients at the Heart of Winning Managed Care Strategy]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_August_30/ai_n27360342]]></link>
		<description><![CDATA[FEASTERVILLE, Pa. -- With Lipitor's formulary access constricting due to generic competition and looming patent expiration, Pfizer aims to extend the health of its flagship cholesterol reducer with an aggressive promotional regimen rivaling that of a new drug in its launch phase. During the first half of 2007 Lipitor was...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 30 Aug 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/microsoft+access.html"><![CDATA[Microsoft Access]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[strategy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[High Court in Dublin Rules in Pfizer's Favor in Patent Case, Lipitor Protected from Generic Competition until 2011]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_July_10/ai_n27298513]]></link>
		<description><![CDATA[NEW YORK -- Pfizer Inc said today that the High Court in Dublin, Ireland has ruled that the basic patent covering atorvastatin - the active ingredient in Lipitor - would be infringed by a competitor product from generics manufacturer Ranbaxy. The decision, which is subject to a possible appeal, prevents...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 10 Jul 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[Generic]]></category>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/ranbaxy.html"><![CDATA[Ranbaxy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Generic Cholesterol Drugs Vital to Helping Consumers, Nation Lower Health-Care Costs]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200704/ai_n21900764]]></link>
		<description><![CDATA[To: MEDICAL EDITORSContact: Susan Herold or Steve Findlay of Consumers Union, +1-202- 462-6262 WASHINGTON, April 3 /PRNewswire-USNewswire/ -- As the maker of Lipitor reportedly urges doctors to carefully consider prescribing generics to lower cholesterol, Consumer Reports Best Buy Drugs reminds consumers that generic statins are as effective as high- priced...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 03 Apr 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/best+buy+co.+inc..html"><![CDATA[Best Buy Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cholesterol.html"><![CDATA[cholesterol]]></category>
		<category domain="http://resources.bnet.com/topic/consumer+reports.html"><![CDATA[Consumer Reports]]></category>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/prescription.html"><![CDATA[prescription]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BBY</category>
		<category domain="tickers">BBY</category>
	</item>
	<item>
		<title><![CDATA[PFIZER INC - Research Update.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5937/is_200703/ai_n23963383]]></link>
		<description><![CDATA[Lipitor Receives FDA Approval for Five New Indications in Patients With Heart                                     Disease ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 07 Mar 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/american+heart+association.html"><![CDATA[American Heart Association]]></category>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/risk.html"><![CDATA[risk]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[PFIZER INC - Research Update.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5937/is_200702/ai_n23963085]]></link>
		<description><![CDATA[New Analysis Shows That Intensive Lipitor Therapy Cuts the Risk of  Hospitalizations Due to Heart Failure in Patients with Coronary Heart Disease                           ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 08 Feb 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/risk.html"><![CDATA[risk]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Data Recently Published in Mayo Clinic Proceedings Showed VYTORINŽ  Superior to Lipitor  in Reducing LDL "Bad" Cholesterol in Patients with Type II Diabetes at the Dose Comparisons Studied]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Dec_21/ai_n27092078]]></link>
		<description><![CDATA[Greater LDL Cholesterol Reduction with VYTORIN Compared to Lipitor Resulted in Greater LDL Cholesterol Goal Attainment]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 21 Dec 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/mayo+clinic.html"><![CDATA[Mayo Clinic]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/vytorin.html"><![CDATA[Vytorin]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Pfizer welcomes Canadian court's Lipitor ruling]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200612/ai_n16940835]]></link>
		<description><![CDATA[NEW YORK AFP &#8212; US drug giant Pfizer said it welcomed a ruling by Canada's Federal Court which prevents Novopharm Ltd. from launching a generic version of its blockbuster anti-cholesterol drug Lipitor until 2010. Pfizer had gone to court in a bid to stop Novopharm marketing a generic version of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 08 Dec 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[PFIZER INC - Lipitor patent in Spain.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5937/is_200610/ai_n23962043]]></link>
		<description><![CDATA[European Patent Office Supports Validity of Lipitor Patent            Madrid, Spain Court of Appeal Confirms Pfizer's Patent Claims        NEW YORK, Oct. 27 -- Pfizer Inc said today that the European Patent Office ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 27 Oct 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[PFIZER INC - Pfizer Lipitor patent case.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5937/is_200610/ai_n23961992]]></link>
		<description><![CDATA[U.S. Appeals Court Denies Ranbaxy Petition for Rehearing Regarding Main Patent                                 in Lipitor Case    ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 24 Oct 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/petition.html"><![CDATA[petition]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/ranbaxy.html"><![CDATA[Ranbaxy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[PFIZER INC - Lipitor patent Netherlands.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5937/is_200609/ai_n23961649]]></link>
		<description><![CDATA[Court in the Netherlands Upholds Basic Lipitor Patent, Prevents Launch of                       Ranbaxy Product Before November 2011        NEW YORK, Sept. 13 --...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 13 Sep 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[PFIZER INC - Research Update.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5937/is_200609/ai_n23961562]]></link>
		<description><![CDATA[Lipitor More Effective Than Simvastatin in Cutting Risk of Additional Heart       Attacks in Patients Who Had a Recent Heart Attack, New Data Suggests        * Heart Disease Patients who Were at a Very High Risk for Having a...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 06 Sep 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Pfizer hits patients&#39; cell phones with Lipitor trials coupons]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qa5351/is_200609/ai_n21398835]]></link>
		<description><![CDATA[PFIZER IS using text messaging to deliver Lipitor trial coupons to consumers. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Sep 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cell+phone.html"><![CDATA[cell phone]]></category>
		<category domain="http://resources.bnet.com/topic/coupon.html"><![CDATA[coupon]]></category>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/phone.html"><![CDATA[phone]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[PFIZER INC - Lipitor Norway Decision.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5937/is_200608/ai_n23961503]]></link>
		<description><![CDATA[Norway Court Decision 'Has No Practical Effect on Pfizer's Ability to Protect       Lipitor from the Launch of a Competitor Generic Product By Ranbaxy'        NEW YORK, Aug. 30 -- Pfizer Inc said today that a Norwegian court ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 30 Aug 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/ranbaxy.html"><![CDATA[RANBAXY]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
</channel>
</rss>
